Long-term PEACE-1 trial results show that adding abiraterone to ADT and docetaxel reduced the risk of death by 32 percent in ...
In the first-in-human TheraPb phase 1 trial, the alpha-emitting radiopharmaceutical 212Pb-ADVC001 was well tolerated at doses ...
A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...
Climate change must be formally declared a global health emergency. And health must influence both climate policies and funding priorities for climate change prevention. This is the appeal launched by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results